STEPHEN FROM - 05 Jan 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Executive Chairman, Director
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Issuer symbol
KPRX
Transactions as of
05 Jan 2022
Net transactions value
-$352
Form type
4
Filing time
06 Jan 2022, 16:10:17 UTC
Previous filing
08 Dec 2021
Next filing
11 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability $352 -326 -0.48% $1.08 67,693 05 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022.